Vertex to Participate in the Wells Fargo Healthcare Conference on Friday, September 9
2022年8月31日 - 9:13PM
ビジネスワイヤ(英語)
Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today
announced that the company will participate in a fireside chat at
the Wells Fargo Healthcare Conference on Friday, September 9, 2022
at 11:00 a.m. ET.
A live webcast of management’s remarks will be available through
Vertex’s website, www.vrtx.com in the “Investors” section under the
“News and Events” page. A replay of the conference webcasts will be
archived on the company’s website.
About Vertex Vertex is a global biotechnology company
that invests in scientific innovation to create transformative
medicines for people with serious diseases. The company has
multiple approved medicines that treat the underlying cause of
cystic fibrosis (CF) — a rare, life-threatening genetic disease —
and has several ongoing clinical and research programs in CF.
Beyond CF, Vertex has a robust pipeline of investigational small
molecule, cell and genetic therapies in other serious diseases
where it has deep insight into causal human biology, including
sickle cell disease, beta thalassemia, APOL1-mediated kidney
disease, pain, type 1 diabetes, alpha-1 antitrypsin deficiency and
Duchenne muscular dystrophy.
Founded in 1989 in Cambridge, Mass., Vertex's global
headquarters is now located in Boston's Innovation District and its
international headquarters is in London. Additionally, the company
has research and development sites and commercial offices in North
America, Europe, Australia and Latin America. Vertex is
consistently recognized as one of the industry's top places to
work, including 12 consecutive years on Science magazine's Top
Employers list and one of the 2021 Seramount (formerly Working
Mother Media) 100 Best Companies. For company updates and to learn
more about Vertex's history of innovation, visit www.vrtx.com or
follow us on Facebook, Twitter, LinkedIn, YouTube and
Instagram.
(VRTX-WEB)
View source
version on businesswire.com: https://www.businesswire.com/news/home/20220831005131/en/
Vertex Pharmaceuticals Incorporated Investors: Manisha
Pai, 617-961-1899 Miroslava Minkova, 617-341-6135
Vertex Pharmaceuticals (NASDAQ:VRTX)
過去 株価チャート
から 6 2024 まで 7 2024
Vertex Pharmaceuticals (NASDAQ:VRTX)
過去 株価チャート
から 7 2023 まで 7 2024